Cargando…

Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature

Context: Metastatic pheochromocytoma/paraganglioma (MPP) therapy mainly involves radionuclide therapy, chemotherapy, and targeted therapy. In recent years, temozolomide (TMZ) showed great promise in some MMP patients, especially those with SDHB germline mutation. We reported a patient with MPP who d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Anli, Li, Ming, Cui, Yunying, Ma, Xiaosen, Wang, Huiping, Li, Yuxiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040234/ https://www.ncbi.nlm.nih.gov/pubmed/32132978 http://dx.doi.org/10.3389/fendo.2020.00061

Ejemplares similares

Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study
por: Ma, Xiaosen, et al.
Publicado: (2020)

Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes
por: Cui, Yunying, et al.
Publicado: (2021)

Mutational Profile and Potential Molecular Therapeutic Targets of Pheochromocytoma
por: Ma, Xiaosen, et al.
Publicado: (2022)

A Novel Phenotype of Germline Pathogenic Variants in MAX: Concurrence of Pheochromocytoma and Ganglioneuroma in a Chinese Family and Literature Review
por: Chang, Xiaoyan, et al.
Publicado: (2020)

Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas
por: Gao, Yinjie, et al.
Publicado: (2021)

Editorial: Predictive tools in pheochromocytoma and paraganglioma
por: Ceccato, Filippo, et al.
Publicado: (2023)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches
por: Kuo, Mickey J. M., et al.
Publicado: (2022)

The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature review
por: Urquhart, Calum, et al.
Publicado: (2022)

Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review
por: Wang, Xu, et al.
Publicado: (2023)

Tumour microenvironment in pheochromocytoma and paraganglioma
por: Martinelli, Serena, et al.
Publicado: (2023)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
por: Szatko, Alicja, et al.
Publicado: (2023)

Surgical Outcomes of Aldosterone-Producing Adenoma on the Basis of the Histopathological Findings
por: Wang, Huiping, et al.
Publicado: (2021)

Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches
por: Costa, Marcia Helena Soares, et al.
Publicado: (2015)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
por: Canu, Letizia, et al.
Publicado: (2019)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Case report: Antiplatelet therapy on metastatic paraganglioma-associated cutaneous vascular disease and literature review
por: Gao, Yinjie, et al.
Publicado: (2022)

The Effects of Different Calcium Channel Blockers on Aldosterone-Producing Adenoma Cells
por: Wang, Fen, et al.
Publicado: (2020)

Clinical differences between small and large pheochromocytomas and paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

Editorial: Recent Advances in Pheochromocytoma and Paraganglioma: Molecular Pathogenesis, Clinical Impacts, and Therapeutic Perspective
por: Islam, Farhadul, et al.
Publicado: (2021)

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
por: Peng, Song, et al.
Publicado: (2020)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

SUN-932 Successful Response of Temozolomide (TMZ) in two Patients with Metastatic Pheochromocytoma/Paragangliomas (PPGLs)
por: de Almeida, Tobias Skrebsky, et al.
Publicado: (2020)

SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis
por: Su, Tingwei, et al.
Publicado: (2023)

Metastatic Pheochromocytomas and Abdominal Paragangliomas
por: Granberg, Dan, et al.
Publicado: (2021)

A Rare Aldosterone-Producing Adenoma Detected by (68)Ga-pentixafor PET-CT: A Case Report and Literature Review
por: Cui, Yunying, et al.
Publicado: (2019)

Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma
por: Wang, Yi, et al.
Publicado: (2022)

Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review
por: Zhao, Bingbin, et al.
Publicado: (2018)

A Predictive Nomogram for Red Blood Cell Transfusion in Pheochromocytoma Surgery: A Study on Improving the Preoperative Management of Pheochromocytoma
por: Guo, Ying, et al.
Publicado: (2021)

Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma
por: Eisenhofer, Graeme, et al.
Publicado: (2022)

Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology
por: Constantinescu, Georgiana, et al.
Publicado: (2022)

Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas
por: Hassan Nelson, Lauren, et al.
Publicado: (2022)

Mutational Profile of Metastatic Pheochromocytoma and Paraganglioma
por: Choi, Yun Mi, et al.
Publicado: (2021)

The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma
por: Wang, Yuxiong, et al.
Publicado: (2023)

Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer
por: Jimenez, Camilo
Publicado: (2018)

Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients
por: Kim, Jung Hee, et al.
Publicado: (2022)

Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
por: Mellid, Sara, et al.
Publicado: (2023)

Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

Lesion-based indicators predict long-term outcomes of pheochromocytoma and paraganglioma– SIZEPASS
por: Hanschell, Helena, et al.
Publicado: (2023)

Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
por: Zheng, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7c0a59luavitf33c2th1ucj7d8